PATRICK DOUGHERTY: Open Payments
NPI 1487985206 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,141 in 17 payments from 10 companies in 2025. Trend: 2023 $745 · 2024 $695 · 2025 $1,141
Food & beverage: $1,141
| Company | Payments | Amount |
|---|---|---|
| Endo USA, Inc. | 5 | $479 |
| TOLMAR, INC. | 3 | $200 |
| Baxter Healthcare | 1 | $146 |
| Astellas Pharma US Inc | 1 | $135 |
| BIOPROTECT MEDICAL, INC. | 1 | $67 |
| Antares Pharma, Inc. | 2 | $29 |
| Ferring Pharmaceuticals Inc. | 1 | $26 |
| Blue Earth Diagnostics | 1 | $20 |
| Myriad Genetic Laboratories, Inc. | 1 | $20 |
| IMMUNITYBIO, INC. | 1 | $19 |
Products named: XIAFLEX, JATENZO, FLOSEAL, Xtandi, BIOPROTECT BALLOON IMPLANT SYSTEM, XYOSTED, ADSTILADRIN, AVEED.
Industry payments across TX — which companies pay providers there.
